Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders.

Journal: Schizophrenia research

Volume: 267

Issue: 

Year of Publication: 

Affiliated Institutions:  Department of Psychiatry, Vagelos College of Physicians & Surgeons Columbia University and New York State Psychiatric Institute, New York, United States of America. Electronic address: yihe.gao@nyspi.columbia.edu. New York State Office of Mental Health, Albany, New York, United States of America. Departments of Psychiatry and Epidemiology, Columbia University, New York and New York State Psychiatric Institute, New York, United States of America.

Abstract summary 

To describe patterns of antipsychotic switching among patients hospitalized for schizophrenia and to correlate antipsychotic switching with hospital readmission risk.We identified 3295 patients with index hospitalizations for schizophrenia or schizoaffective disorder from New York State Medicaid claims 2017-2018 who had filled at least one prescription for an antipsychotic in both the 44 days (one month +14 day grace period) prior to and after their admission. We identified patients who had kept or switched any of their antipsychotic medication between the pre- and post-periods surrounding their index hospitalization. We compared the kept and switched any groups, adjusting for patient characteristics.Of patients who had filled antipsychotic prescriptions in both the 44 days prior to and after their hospitalization, 1599 (48.6 %) had switched at least one antipsychotic and 1215 (36.8 %) had switched their primary antipsychotic. Switching any antipsychotic was associated with increased hazards of readmission, HR = 1.21, 95%CI 1.09-1.35, which was slightly concentrated during the first 90 days after hospital discharge.Switching antipsychotic medications during hospitalization occurs commonly and is associated with higher rehospitalization risk following hospital discharge.

Authors & Co-authors:  Gao Wang Gu Chung Olfson

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  5
Identifiers
Doi : 10.1016/j.schres.2024.03.034
SSN : 1573-2509
Study Population
Male,Female
Mesh Terms
Other Terms
Antipsychotics;Schizophrenia;Switching
Study Design
Study Approach
Country of Study
Publication Country
Netherlands